| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |